Norges Bank’s Theriva Biologics TOVX Stock Holding History

Norges Bank’s Portfolio TOVX Stock Details TOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-53	Closed	-$356K	–	2181
2016 Q4	$356K	Hold	53	–	–	﹤0.01%	2129
2016 Q3	$767K	Hold	53	–	–	﹤0.01%	2076
2016 Q2	$840K	Hold	53	–	–	﹤0.01%	2087
2016 Q1	$1.1M	Hold	53	–	–	﹤0.01%	2051
2015 Q4	$1.07M	Sell	53 -3	-5%	-$63.5K	﹤0.01%	2100
2015 Q3	$1.12M	Buy	+56	New	+$1.38M	﹤0.01%	2098

Other funds holding TOVX

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank's TOVX Position: Q1 2017 in Review

Norges Bank sold out of Theriva Biologics (TOVX) in Q1 2017, closing a stake of 53 shares — an estimated $356K sold.

Norges Bank first reported a position in TOVX in Q3 2015 and held it in 6 quarters. The position peaked at $1.12M in Q3 2015. 74 funds tracked by Wall St. Rank hold TOVX as of Q1 2017.

Norges Bank reported no remaining Theriva Biologics position as of Q1 2017 after selling out during the quarter.
Norges Bank sold 53 Theriva Biologics shares in Q1 2017, an estimated $356K.
Norges Bank first reported a position in Theriva Biologics in Q3 2015 and held it in 6 quarters.
Norges Bank's Theriva Biologics position peaked at $1.12M in Q3 2015.
74 funds tracked by Wall St. Rank held Theriva Biologics as of Q1 2017.

Based on Norges Bank's 13F filing for Q1 2017, filed 10 May 2017.